Genito-Crural Island Perforator Flap (GCIPF) for Vulvar Reconstruction
The genito-crural island perforator flap (GCIPF) is a fasciocutaneous island perforator flap harvested from the genitocrural (labiocrural / genitofemoral) sulcus, based on perforators from the anterior branch of the obturator artery and / or the internal pudendal artery system. Championed by the Toulouse group (Commenge, Ricotta, Martinez et al.) as a simple, reliable, first-line reconstructive option for vulvar cancer defects — the largest dedicated series (2025) demonstrated no total flap necrosis in 46 flaps, a median hospitalization of 4 days, and 78.3% complete vulvar healing within 4 weeks.[1][2]
For the broader treatment menu see the Vulvar Reconstruction Atlas. For related parent / sibling flaps see the foundations Lotus Petal, Singapore / pudendal-thigh, IGAP / Gluteal-Fold, IPAP, and SCIP pages.
Anatomic Basis and Nomenclature
The genitocrural sulcus (sulcus genitofemoralis / labiocrural fold) is the natural crease between the vulva and the medial thigh — ideal as a donor site because of its thin, pliable tissue immediately adjacent to the vulva.[3][4]
The GCIPF is the modern perforator-based refinement of several historically described flaps from the same anatomic territory:
| Related flap | First described | Relationship to GCIPF |
|---|---|---|
| Pudendal-thigh (Singapore) | Wee & Joseph 1989 | Original axial-pattern flap from the genitocrural region[4] |
| Lotus petal | Yii & Niranjan 1996 | Genitocrural sulcus = "upper petal" of the lotus design[4] |
| Anterior obturator artery perforator (aOAP) | O'Dey 2010 | Cadaveric anatomic foundation of GCIPF[3] |
| IPAP flap | Hashimoto 2014 | Free-style perforator concept from the broader perineal territory[5] |
| Perineal perforator switch flap (PPSF) | Shin 2022 | Tunneled island perforator flap around perforators close to the genitofemoral sulcus[6] |
"Genito-crural island perforator flap" as used by the Toulouse group is a unifying, anatomically descriptive name for a perforator-based island flap from the genitocrural sulcus — incorporating the O'Dey aOAP vascular territory and the Hashimoto IPAP design philosophy.[1][2][3][5]
Vascular Anatomy
Primary supply — aOAP (O'Dey 2010 cadaveric study, n = 10 corpses / 20 specimens)[3]
- The sulcus genitofemoralis is supplied by a perforator from the anterior branch of the obturator artery with its accompanying vein.
- The aOAP was present in 100% of specimens.
- Two perforator types:
- Musculocutaneous (80%, 16/20) — pierces the gracilis muscle.
- Septocutaneous (20%, 4/20) — passes the posterior border of the gracilis.
- Perforator location: 1.3 ± 0.3 cm lateral to the inferior pubic ramus.
- aOAP skin territory: ~7 × 15 cm centered on the sulcus genitofemoralis.
Contributing supply (Höckel 2008)[4]
| Source | Territory |
|---|---|
| External pudendal aa. (superficial / deep) | Anterior / upper perineal |
| Internal pudendal a. perforators | Medial / posterior |
| Obturator a. perforators | Lateral (dominant per O'Dey) |
| Medial circumflex femoral a. | Medial thigh |
These form a dense epifascial / subfascial network — exceptional vascular redundancy.
Sensory innervation
- Perineal branches of the pudendal nerve — primary supply to the medial portion.[7]
- Ilioinguinal and genitofemoral nerves — contribute to the anterior / upper territory.
- The flap retains cutaneous innervation of the corresponding perineal region.[4][7]
Indications
| Indication | Detail |
|---|---|
| Hemivulvectomy | Unilateral GCIPF[1] |
| Radical / total vulvectomy | Bilateral GCIPF (19/27 patients in Commenge bilateral)[1] |
| Vulvar squamous cell carcinoma | Primary indication |
| Extramammary Paget disease | Reliable coverage |
| Vulvar melanoma | — |
| Vulvar dysplasia / VIN | — |
The Toulouse group uses this flap routinely as their first-line reconstructive option in tertiary cancer-center practice.[1]
Surgical Technique (Commenge 2025)[1]
- Position — lithotomy.
- Design — island skin paddle along the genitocrural sulcus / labiocrural fold, centered over the perforator, sized to the defect.
- Perforator identification — handheld Doppler in the genitocrural sulcus, ~1.3 cm lateral to the inferior pubic ramus.[3]
- Incision and elevation — circumferential incision; raised as a true island flap on its perforator pedicle, preserving the soft tissue around the pedicle.
- Transfer — transposed or tunneled into the vulvar defect. The tunneled variant (per O'Dey) avoids visible skin bridges and yields superior aesthetic results.[3]
- Inset — sutured with attention to 3D vulvar-contour restoration.
- Donor closure — primary, with the scar concealed in the natural labiocrural fold.
Key technical points:
- Raise unilaterally or bilaterally depending on defect size.[1]
- Provides thin, pliable tissue closely matching vulvar skin — unlike bulkier musculocutaneous flaps.[3]
- The tunneled aOAP island design offers outstanding characteristics for anatomically normal vulvar reconstruction with scars limited within the urogenital region.[3]
Outcomes — Commenge et al. (2025), the largest dedicated GCIPF series[1]
| Parameter | Result |
|---|---|
| Patients | 27 |
| Total flaps | 46 (19 bilateral, 8 unilateral) |
| Median age | 61 y (range 35–81) |
| Median BMI | 27.7 kg/m² (range 18.7–43.6) |
| Smokers | 44.4% |
| No risk factors for impaired healing | 59.3% |
| Total flap necrosis | 0% |
| Complete vulvar healing < 4 wk | 78.3% |
| Complete vulvar healing > 8 wk | 4.3% |
| Donor-site healing < 4 wk | 69.6% |
| Donor-site healing > 8 wk | 2.2% |
| Median hospitalization | 4 d (range 1–15) |
| Overall complication rate | 33.3% |
| Wound dehiscence | 17.4% |
| Local infection | 21.7% |
| Life-threatening complications | 0% |
| Delay in adjuvant RT | None |
Position in the Toulouse Algorithm (2025)[2]
The Toulouse algorithm prioritizes perforator flaps first-line based on the anatomical involvement of the vulvo-perineal region rather than defect size — a departure from prior size-based algorithms (Salgarello 2005, Negosanti 2015, Höckel 2008).
- The GCIPF (with IPAP and DFAP) is a primary reconstructive option for most vulvar defects.
- Musculocutaneous flaps are reserved for selected cases when perforator flaps are not feasible.
- Aim: more accurate anatomical restoration, preserving self-image and sexual function without compromising oncologic outcome.
Comparison with Related Perforator Flaps
| Feature | GCIPF | IPAP | DFAP / PAP |
|---|---|---|---|
| Primary source | Anterior obturator a. | Internal pudendal a. | Profunda femoris a. |
| Donor site | Genitocrural sulcus (labiocrural fold) | Ischiorectal fossa / gluteal fold | Posteromedial thigh |
| Tissue thickness | Very thin and pliable | Thin (can be thinned) | Moderate (can be thinned) |
| Skin territory | ~7 × 15 cm | Variable | Variable (large) |
| Best for | Lateral / anterior vulvar | Posterior / lateral vulvar | Lateral / extended; irradiated fields |
| Scar location | Labiocrural fold (concealed) | Gluteal fold (concealed) | Posteromedial thigh (visible) |
| Flap survival | 100% (no total necrosis) | 94.4% complete; no total loss | 100% in vulvar series |
| Wound complications (IPAP vs DFAP) | — | 12.9% | 37.5% (p = 0.04)[9] |
Han et al. (2023) demonstrated IPAP flaps had significantly fewer wound complications (12.9%) than DFAP / TUG flaps (37.5%) (p = 0.04) in a 47-patient series — suggesting perforator flaps from the perineal territory (including the genitocrural region) may be superior to those from the more lateral thigh.[9]
Comparison with Other Vulvar Reconstruction Approaches
Perforator vs non-perforator flaps (Wendelspiess meta-analysis 2024, n = 1,840)[10]
- Overall short-term surgical complication rate comparable between perforator (n = 276) and non-perforator (n = 1,564) flaps (p > 0.05).
- Tendency toward fewer complications with perforator flaps.
- QOL assessment scarce across studies.
Pedicled perforator flaps for vulvar reconstruction (Huang 2015, n = 16 / 27 flaps)[8]
- Multiple perforator flap types (DFAP, MCFAP, EPAP, IPAP, free-style).
- 100% flap survival across all perforator types.
- All donor sites closed primarily; no donor-site morbidities.
- All patients satisfied with cosmetic / functional results (except 1 requiring debulking).
- Concluded perforator flaps provide thinner fasciocutaneous coverage with favorable outcomes and fewer donor-site morbidities vs traditional musculocutaneous flaps.
Perineal perforator switch flap (Shin 2022, n = 16 / 27 flaps)[6]
- Perforators identified close to the genitofemoral sulcus — same territory as GCIPF.
- Island flap centered on the perforator, tunneled subcutaneously without pedicle skeletonization.
- 100% flap survival; no major surgical complications.
- Mean OR time 79.4 ± 19.7 min; hospitalization 5.69 ± 0.79 d.
- Superior aesthetic results vs perineal perforator propeller flap in symmetry (p = 0.015) and labial shape (p = 0.031).
- Did not delay adjuvant RT.
Advantages
| Advantage | Detail |
|---|---|
| Ideal tissue match | Thin, pliable, immediately adjacent to the vulva — closely matches vulvar skin in color / texture / thickness[3] |
| Concealed donor scar | Hidden in the labiocrural fold; scars limited within the urogenital region[1][3] |
| No total flap necrosis | 0% total flap loss in Commenge (46 flaps)[1] |
| Rapid healing | 78.3% complete vulvar healing within 4 wk[1] |
| Short hospitalization | Median 4 d (range 1–15)[1] |
| No adjuvant-RT delay | Vulvar RT administered without delay[1] |
| Simple and reliable | "Simple and reliable procedure" routinely usable in a tertiary cancer center[1] |
| Constant vascular anatomy | aOAP present in 100% of cadaveric specimens; perforator location predictable (~1.3 cm lateral to inferior pubic ramus)[3] |
| No muscle sacrifice | Fasciocutaneous / perforator design[3][8] |
| Sensate | Retains cutaneous innervation of the perineal region[4][7] |
| Versatile | Unilateral or bilateral; hemivulvectomy through total vulvectomy[1] |
| Primary donor closure | All donor sites closed primarily[1][8] |
| Compatible with inguinofemoral LND | Donor pedicle preserved[7] |
Limitations
| Limitation | Detail |
|---|---|
| Limited published data | Commenge 2025 is the only dedicated GCIPF series to date (n = 27 / 46 flaps); larger multicenter studies needed[1] |
| 33.3% overall complication rate | No total flap necrosis, but wound dehiscence (17.4%) and local infection (21.7%) common[1] |
| Limited skin territory | aOAP ~7 × 15 cm — may be insufficient for very large or extended defects requiring pelvic dead-space obliteration[3] |
| No volume | Thin fasciocutaneous flap cannot fill large pelvic dead space after exenteration — musculocutaneous flaps required[4] |
| Perforator variability | aOAP type is musculocutaneous in 80% vs septocutaneous in 20% — affects dissection difficulty[3] |
| No long-term QOL data | Commenge reports surgical outcomes only; no validated QOL or sexual-function assessment[1] |
| Potential conflict with medially extended LND | Vascular pedicle at risk if groin dissection extended medially[4] |
| Lack of comparative studies | No head-to-head comparison with IPAP, DFAP, V-Y, or lotus-petal for the GCIPF specifically |
Key Takeaways
- The GCIPF is a thin, sensate, perforator-based island flap from the labiocrural fold on the anterior obturator artery perforator and / or IPA perforators.[1][3]
- Cadaveric anatomic foundation established by O'Dey 2010 — aOAP present in 100% of specimens, predictable location, ~7 × 15 cm skin territory.[3]
- Commenge 2025 (n = 46) — 0% total flap necrosis, 78.3% healing within 4 wk, median 4-d hospitalization, no adjuvant-RT delay.[1]
- Positioned as a first-line perforator flap in the Toulouse algorithm 2025 — perforator flaps prioritized over musculocutaneous flaps by anatomical location.[2]
- Key advantages: ideal tissue match (thin, pliable, immediately adjacent to vulva), concealed labiocrural-fold scar, simple reliable harvest.[1][3]
- Main limitations: relatively small skin territory (not suitable for extended defects or pelvic dead-space obliteration) and limited published evidence beyond a single-center series.[1][3]
References
1. Commenge V, Martinez A, Ricotta G, et al. Use of the genito-crural island perforator flap in vulvar reconstruction: a single-center experience. Int J Gynecol Cancer. 2025;36(2):102847. doi:10.1016/j.ijgc.2025.102847
2. Ricotta G, Russo SA, Ferron G, Meresse T, Martinez A. The Toulouse algorithm: vulvar cancer location-based reconstruction. Int J Gynecol Cancer. 2025;35(4):100065. doi:10.1016/j.ijgc.2024.100065
3. O'Dey DM, Bozkurt A, Pallua N. The anterior obturator artery perforator (aOAP) flap: surgical anatomy and application of a method for vulvar reconstruction. Gynecol Oncol. 2010;119(3):526–530. doi:10.1016/j.ygyno.2010.08.033
4. Höckel M, Dornhöfer N. Vulvovaginal reconstruction for neoplastic disease. Lancet Oncol. 2008;9(6):559–568. doi:10.1016/S1470-2045(08)70147-5
5. Hashimoto I, Abe Y, Nakanishi H. The internal pudendal artery perforator flap: free-style pedicle perforator flaps for vulva, vagina, and buttock reconstruction. Plast Reconstr Surg. 2014;133(4):924–933. doi:10.1097/PRS.0000000000000008
6. Shin J, Kim SA, Rhie JW. Perineal perforator switch flap for three-dimensional vulvovaginal reconstruction. J Plast Reconstr Aesthet Surg. 2022;75(9):3208–3216. doi:10.1016/j.bjps.2022.04.052
7. Moschella F, Cordova A. Innervated island flaps in morphofunctional vulvar reconstruction. Plast Reconstr Surg. 2000;105(5):1649–1657. doi:10.1097/00006534-200004050-00008
8. Huang JJ, Chang NJ, Chou HH, et al. Pedicle perforator flaps for vulvar reconstruction — new generation of less invasive vulvar reconstruction with favorable results. Gynecol Oncol. 2015;137(1):66–72. doi:10.1016/j.ygyno.2015.01.526
9. Han WY, Kim Y, Han HH. A simplified algorithmic approach to vulvar reconstruction according to various types of vulvar defects. Ann Plast Surg. 2023;91(2):270–276. doi:10.1097/SAP.0000000000003597
10. Wendelspiess S, Kouba L, Stoffel J, et al. Perforator versus non-perforator flap-based vulvoperineal reconstruction — a systematic review and meta-analysis. Cancers. 2024;16(12):2213. doi:10.3390/cancers16122213